RMND1 and Hypergonadotropic hypogonadism: Ovarian dysfunction (ovarian atrophy and hypergonadotropic hypogonadism) as a consequence of RMND1 pathogenic variants has been previously reported only once in a patient described by Demain et al. [6] and in none of the approximately 40 patients with OXPHOS deficiency.